Interestingly, several metabolic pathways are shown to be enriched in CD8+ high ROIs compared to both CD8+ intermediate and CD8+ low ROIs, such as glucose metabolism, pyruvate metabolism, TCA cycle and respiratory electron transport, which aligns with the high energetic demands required by active Teff cells engaging anti-tumor activity. The gene discussed is CD8A; the disease is neoplasm.